Leonard Weinstock, MD - Mast cell activation syndrome and potential role for LDN (2019 Conference) (LDN, low dose naltrexone)

Leonard Weinstock, MD discusses LDN  for MCAS and SIBO at the LDN 2019 Conference. He discusses the etiology, symptoms, testing, and therapy for MCAS, SIBO, and POTS; and presents related cases.
 

Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD - Causes of Hashimoto's (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD discusses Hasimoto’s thyroiditis at the LDN 2019 Conference. He discusses the mechanisms of thyroid dysfunction, causes and evaluation of Hashimoto’s thyroiditis, Hashimoto’s in obesity, and treatments of Hasimoto's
 

Harpal Bains, MBBS - Biodentical hormones+asthetic+lifestyle (2019 Conference) (LDN, low dose naltrexone)

Dr Harpal Bains, MBBS discusses the interaction between bioidentical hormones, aesthetics, and lifestyle. She talks on the major hormone, immune disorders, environmental toxins, nutritional effects, particularly cortisol. She presents a treatment approach including hormones, nutrients, and LDN.

Dana Keaton, ND - The scope of patient selection for LDN (2019 Conference) (LDN, low dose naltrexone)

Amy Lamb, Pharm - A Pharmacist's Perspective on Comprehensive Immune Health Consultations and Applications of LDN (2019 Conference) (LDN, low dose naltrexone)

Deirdre - US: Small Intestinal Bacteria Overgrowth (SIBO) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Deirdre shares her SIBO and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.

Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'm joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today. 

Vera - US: Dermatomyositis, Microscopic Colitis (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Yusuf (JP) Saleeby, LDN Radio Show 08 Feb 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Thank you for joining us today, Dr Saleeby. 

Dr Yusuf Saleeby: It's very good to be here, Linda.